Parkinson's Disease

A progressive neurodegenerative disorder caused by loss of dopaminergic neurons, marked by resting tremor, rigidity, bradykinesia, and postural instability, with associated non-motor symptoms.

Phase 1/2 and later readouts in Parkinson's Disease, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

Total attributable cost

$25.4B

$24,439/patient

Drug spend

Not yet sourced

How this is calculated ↗

All severities (2017 MEPS-anchored estimate) · US

All assets in Parkinson's Disease

← Neurology